FMR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.81377135533012E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.06260042168572E-10 |
Normal-vs-Stage2 |
3.026400E-04 |
Normal-vs-Stage3 |
1.10589981616727E-10 |
Normal-vs-Stage4 |
8.04800670550776E-12 |
Stage1-vs-Stage2 |
9.592600E-01 |
Stage1-vs-Stage3 |
5.171700E-02 |
Stage1-vs-Stage4 |
2.776100E-02 |
Stage2-vs-Stage3 |
2.183400E-01 |
Stage2-vs-Stage4 |
1.955450E-01 |
Stage3-vs-Stage4 |
9.961000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.96065386148803E-12 |
Normal-vs-AfricanAmerican |
6.16270000031172E-07 |
Normal-vs-Asian |
9.083500E-02 |
Caucasian-vs-AfricanAmerican |
7.752000E-01 |
Caucasian-vs-Asian |
4.136200E-01 |
AfricanAmerican-vs-Asian |
3.321800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.4311446713059E-12 |
Normal-vs-Female |
1.62281299509459E-12 |
Male-vs-Female |
3.380200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.5445999999606E-06 |
Normal-vs-Age(41-60Yrs) |
4.6886999838236E-09 |
Normal-vs-Age(61-80Yrs) |
1.80955250783654E-12 |
Normal-vs-Age(81-100Yrs) |
8.76710037900352E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.860000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.453400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.343400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.980300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.763000E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.988300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.750590E-01 |
Normal-vs-Grade 2 |
6.84950000051643E-07 |
Normal-vs-Grade 3 |
1.62614366416847E-12 |
Normal-vs-Grade 4 |
1.64546154479694E-12 |
Grade 1-vs-Grade 2 |
3.897600E-01 |
Grade 1-vs-Grade 3 |
6.681200E-03 |
Grade 1-vs-Grade 4 |
1.902230E-03 |
Grade 2-vs-Grade 3 |
2.743800E-03 |
Grade 2-vs-Grade 4 |
2.629200E-04 |
Grade 3-vs-Grade 4 |
1.211370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.92640000407485E-08 |
Normal-vs-ccB subtype |
7.24799997797732E-10 |
ccA subtype-vs-ccB subtype |
1.892040E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.21930251953495E-11 |
Normal-vs-N1 |
2.24440000029524E-07 |
N0-vs-N1 |
3.001800E-01 |
|
|